What WeInnovate Biosolutions does
Founded in 2016, WeInnovate Biosolutions operates in Health Tech industry. Initially, the company focussed on creating a wound healing gel utilising their proprietary nanotechnology, allowing for efficient infection management. They have launched a series of nalidixic acid-based products that address multi-drug resistant bacterial infections, enhancing patient care. WeInnovate Biosolutions has expanded its offerings to include a line of antimicrobial coatings and solutions for medical devices, thus broadening their impact within the healthcare sector. Competing with companies such as Pandorum Technologies and String Bio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about WeInnovate Biosolutions yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.